glp-1 news today 2025 october 9 Regulating a "Miracle Drug": Costs, Access, & Safety GLP-1 Receptor Agonist Market Size

Istitut Panum, Universit ta' Kopenagen, id-Danimarka

Pan et al., 2023)

The approval is the second for Krazati, which is also FDA-authorized to treat KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer

Potent Antioxidant ProtectionRich in polyphenols, catechins, and EGCG, green tea extract helps combat oxidative stress and supports immune health

Injections, being quick and requiring fewer sessions, might better suit a busy lifestyle

Users remain on therapy for many months or years they need repeated lab checks, dose titration, short interval follow-ups and tight hand-offs between prescriber and pharmacy